Home Arca Biopharma Upgraded to "Buy" by Zacks
 

Keywords :   


Arca Biopharma Upgraded to "Buy" by Zacks

2015-09-06 11:55:06| Biotech - Topix.net

The firm currently has a $1.25 target price on the biopharmaceutical company's stock. Zacks 's price target would suggest a potential downside of 80.47% from the stock's previous close.

Tags: buy upgraded arca zacks

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
28.06Diversified Labeling Solutions expands RFID capabilities
28.06Eastern North Pacific Tropical Weather Outlook
28.06Atlantic Tropical Weather Outlook
28.06Commitment leads to success in cattle marketing
28.06Kurz opens new facility in Germany
28.06Apex invests in Schepers laser engraving technology
28.06All4Labels opens first factory in Northeast Brazil
28.06WOW Conference Attracts Industry Leaders to Minneapolis
More »